Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 3.470
-0.130 (-3.61%)
Nov 2, 2026, 3:36 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 366.14 million as of November 2, 2026. It is the 31,904th most valuable company in the world and the 428th biggest in Sweden. Its market cap has increased by 397.13% in one year.
Market Cap
366.14M
Enterprise Value
272.88M
Revenue
139.36M
Global Rank
Country Rank
#428 Sweden
PE Ratio
4.91
ChartMarket Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 366.14M, an increase of 485.88%. That is a compound annual growth rate of 15.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 366.14M | 136.05% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Corline Biomedical AB | 371.09M |
| BioInvent International AB | 357.32M |
| Mendus AB | 352.63M |